Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.5200 (-0.61%) ($88.8300 - $90.7000) on Tue. Sep. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.26% (three month average) | RSI | 25 | Latest Price | $89.5200(-0.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.4% a day on average for past five trading days. | Weekly Trend | LGND declines -4.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.13% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.13% (StdDev 2.26%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $85.56(-4.42%) | Resistance Level | $98.82 | 5 Day Moving Average | $92.16(-2.86%) | 10 Day Moving Average | $95.55(-6.31%) | 20 Day Moving Average | $98.82(-9.41%) | To recent high | -29.4% | To recent low | 0% | Market Cap | $1.439b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |